<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339"><gtr:id>EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339</gtr:id><gtr:name>European Commission</gtr:name><gtr:address><gtr:line1>Wetstraat 200 / Rue de la Loi 200</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:department>College of Medical, Veterinary &amp;Life Sci</gtr:department><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339"><gtr:id>EF6B1E83-9BAD-4ED0-B2A0-5E1A69687339</gtr:id><gtr:name>European Commission</gtr:name><gtr:address><gtr:line1>Wetstraat 200 / Rue de la Loi 200</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/08A4D1EB-4378-42AF-BF0C-57A5206DF45A"><gtr:id>08A4D1EB-4378-42AF-BF0C-57A5206DF45A</gtr:id><gtr:firstName>Ellen</gtr:firstName><gtr:otherNames>Marie</gtr:otherNames><gtr:surname>Freel</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0802803"><gtr:id>0DB709B4-0B4E-4012-8FAB-D6F31629E656</gtr:id><gtr:title>Cardiovascular Disease: Investigating the Expanding Role of Aldosterone</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0802803</gtr:grantReference><gtr:abstractText>Worldwide, 8 million deaths have been attributed to high blood pressure (hypertension) per year. This accounts for at least half of all annual deaths from cardiovascular disease (stroke, heart attacks). Despite considerable research, the underlying causes of high blood pressure in most cases remain unclear. This proposal focuses on steroid hormones produced by the human adrenal gland and uses a number of techniques to examine their role in hypertension and cardiovascular disease. In particular, the effect of variation within genes that control the production of steroid hormones will be explored in a cohort of normal volunteers in order to clarify further the genetic basis of hypertension caused by excess of a key steroid hormone, aldosterone. The potentially harmful effect of this hormone on heart structure and function will also be investigated in patients with hypertension due to aldosterone excess using detailed magnetic resonance imaging scans. Finally, how steroid hormones interact with other factors including diet and salt intake to regulate blood pressure levels will also be explored in a large group of patients from different ethnic backgrounds.
 
The planned studies should result in a better understanding of mechanisms that lead to hypertension and cardiovascular disease and more effective targeting of treatments as well as earlier identification of those most at risk of developing hypertension and its associated problems.</gtr:abstractText><gtr:technicalSummary>Hypertension is the most important cardiovascular risk factor, and results in substantial morbidity and mortality. Aldosterone plays an important role in the pathophysiology of hypertension and cardiovascular disease. The proposed studies will use a variety of approaches to explore the key role of aldosterone and other adrenal corticosteroids in the aetiology of hypertension and in mediating end-organ damage. 
Regulation of aldosterone secretion-role of activation of HPA axis: I intend to build on previous findings from my Wellcome Trust Clinical Fellowship which demonstrated an association between novel variants in steroid synthetic genes (aldosterone synthase, CYP11B2 and 11? hydroxylase, CYP11B1) and an altered ACTH/cortisol relationship. Normal subjects will be genotyped across the CYP11B locus and their hypothalamic/anterior pituitary axis will be assessed by measuring ACTH response to corticotrophic releasing hormone (CRH) stimulation. Subjects will undergo assessment of adrenal volume using magnetic resonance imaging (MRI) allowing relationships among genotype, corticosteroid production and adrenal volume to be explored.
Cardiovascular consequences of primary aldosteronism (PA): The proposal that subjects with hypertension due to aldosterone excess have more cardiovascular damage than subjects with equivalent essential hypertension will be investigated in more detail. Briefly, PA subjects and individually matched subjects with essential hypertension will undergo assessment of peripheral and central vascular stiffness, plasma oxidative stress markers as well as cardiac imaging using MRI with gadolinium enhancement (to demonstrate cardiac fibrosis). 
Aldosterone and renal end organ damage: The interaction of urinary aldosterone and sodium in predicting progression will be examined in two cohorts:-diabetic and non-diabetic nephropathy, and in hypertensive controls. Plasma renin and aldosterone, as well as urinary sodium, aldosterone and albumin excretion will be measured at a single baseline visit and renal progression (measured by estimated glomerular filtration rate and urine albumin excretion) assessed at 1 and 2 years. In addition, I will assess oxidative stress as well as vascular stiffness at baseline and after 2 years to investigate whether there is an influence of aldosterone on rate of vascular damage in such patients. 
Urinary Biomarkers of hypertension and cardiovascular risk: This study, investigating the role of aldosterone as a biomarker that relates to level of blood pressure amongst individuals and its interaction with sodium in relation to blood pressure, will be performed in collaboration with Professor Paul Elliott of Imperial College, London who co-ordinated the INTERMAP study of 4600 individuals (across UK, USA, Japan and China). I plan to examine how measurements of urinary excretion of aldosterone and other corticosteroid metabolites using Gas Chromatography Mass Spectrometry (GCMS) interact with sodium status to determine blood pressure and cardiovascular risk. In addition, I intend to spend a period of three months in Imperial College under the supervision of Professor Elliott gaining experience in the management and analysis of large datasets.</gtr:technicalSummary><gtr:fund><gtr:end>2014-10-01</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-08-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>964786</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>European Commission</gtr:collaboratingOrganisation><gtr:country>European Union (EU)</gtr:country><gtr:department>Horizon 2020</gtr:department><gtr:description>Omics-based strategies for improved diagnosis and treatment of endocrine hypertension</gtr:description><gtr:id>03D8F856-CBD0-453C-B1D9-CC4029A9B7AF</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>56d42e5256a6a0.14559088-1</gtr:outcomeId><gtr:partnerContribution>Led by Professor Maria Christina Zennaro</gtr:partnerContribution><gtr:piContribution>One of 5 European Centres (and only 2 UK centres) contributing to this project. I am a local investigator and lead local investigator is Professor Eleanor Davies. My main role is identify and recruit patients with hypertension +/- adrenal adenoma for further study.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Visit to Soroptomist Society Glasgow</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>FE2D8670-1A0F-4F84-8C38-50A9A00774AF</gtr:id><gtr:impact>Each talk attended by 40 professional local women. All very interested to hear of local research.

Benefited from local fundraising efforts.
Increased recruitment into clinical studies</gtr:impact><gtr:outcomeId>eWCm9HpLvor</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Faculty member of Society for Endocrinology Career Development Workshop</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>BA4C8F9C-CEC7-4604-98D0-037EDADC6669</gtr:id><gtr:impact>I developed and led the new 'track 2' component of the CDW (with Dr Gareth Lavery, Birmingham). The aim was to provide support and advice to post doctoral researchers (clinical and non-clinical) to help with Intermediate Fellowship applications

Excellent feedback. Now co-ordinating a 'coaching' scheme through the Society where we fcailitate individual mentorship/coaching for applications</gtr:impact><gtr:outcomeId>YW49xdkArYF</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:url>http://www.endocrinology.org/meetings/CDW/</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Medical Education Lead: Society for Endocrinology</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>4D9057D8-525E-4154-8C8F-4EAA988C56A5</gtr:id><gtr:impact>Ensure undergraduate students are aware of endocrinology as a career choice. Helped develop and edit Society for Endocrinology booklet on careers in endocrinology

A number of students have contacted me asking to do SSC in Endocrinology</gtr:impact><gtr:outcomeId>545b455dbd9f48.39538017</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Undergraduate students</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>British hypertension society masterclass</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>36DA9F59-069C-4327-8AE2-0894ED3872B4</gtr:id><gtr:impact>Audience consisted of lay people, researchers and health professionals. Debate around frequency of hypertension and public health messages that must be conveyed

Possible collaboration with cardiologists and multi centre study</gtr:impact><gtr:outcomeId>KrCwrCMysKD</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit (Glasgow)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>44A3BC37-ADC6-4A3E-9A62-AACDB057C4BD</gtr:id><gtr:impact>Gave talk on medicine/science as a possible career to group of local schoolchildren

Contacted by several school pupils and have arranged several clinical/laboratory placements</gtr:impact><gtr:outcomeId>LDL93mik2cJ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>217570</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CSO project grant (co-investigator)</gtr:description><gtr:end>2015-08-02</gtr:end><gtr:fundingOrg>Chief Scientist Office (CSO)</gtr:fundingOrg><gtr:id>941A083A-4132-44DD-89FE-CE7295C01B70</gtr:id><gtr:outcomeId>NMFBwHvSDf6</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>69450</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Centenary Award</gtr:description><gtr:end>2013-10-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>CA962757-2F92-499C-88EA-69C403C6259A</gtr:id><gtr:outcomeId>gcjLfH7sAgy</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>10000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>INSPIRE Programme</gtr:description><gtr:end>2015-08-02</gtr:end><gtr:fundingOrg>Academy of Medical Sciences (AMS)</gtr:fundingOrg><gtr:id>23376365-AC6A-4D8B-9C2A-0AEC0D2E4DD9</gtr:id><gtr:outcomeId>545b45d44257b9.41941031</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>135134</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Kidney Research UK Training Fellowship (co PI)</gtr:description><gtr:end>2015-06-02</gtr:end><gtr:fundingOrg>Kidney Research UK</gtr:fundingOrg><gtr:fundingRef>TF6/2013</gtr:fundingRef><gtr:id>BD5DBB47-BE42-4EB3-A954-26D747145E62</gtr:id><gtr:outcomeId>H75LQz3mVps</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>8500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>NHS Greater Glasgow and Clyde Endowments</gtr:department><gtr:description>NHS GG&amp;amp;C Endowment award</gtr:description><gtr:end>2015-11-02</gtr:end><gtr:fundingOrg>NHS Greater Glasgow and Clyde (NHSGGC)</gtr:fundingOrg><gtr:id>4B1470A9-FA5E-4279-9175-5418B35A41EA</gtr:id><gtr:outcomeId>tMzNZLkTu3S</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-11-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of Society for Endocrinology Clinical Committee</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>66C0D412-0318-45A3-930C-55D1888E7F0E</gtr:id><gtr:outcomeId>WD1pvDcGPYC</gtr:outcomeId><gtr:type>Membership of a guidance committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of the American Endocrine Society Self Assessment Committee</gtr:description><gtr:geographicReach>North America</gtr:geographicReach><gtr:id>4BCAE4B1-2FCC-4815-B905-0A97D69F092C</gtr:id><gtr:impact>I am a member of an international group of clinicians selected by the American Endocrine Society. We write clinical questions designed to aid the education of endocrine trainees in passing their American Board exams as well as ensuring continuing medical education of American Endocrinologists who require to recertify with the American Board of Internal Medicine every 5-10 years.</gtr:impact><gtr:outcomeId>545b4a2c9f0217.69820997</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of question writing group for MRCP (Diabetes &amp;amp; Endocrinology)</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6A49850C-1961-471E-ADAE-85A0F422C247</gtr:id><gtr:outcomeId>AhGZzknLQYs</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Participated in Royal Colleges 'Research Summit'</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>FD0A1C2F-461F-4734-92A5-B80ABA6F6494</gtr:id><gtr:outcomeId>pHrqmSEJe7T</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Glasgow Blood Pressure Clinic database: contains detailed phenotypic data from &amp;gt; 30000 patients dating back over 40 years</gtr:description><gtr:id>D42786DB-73E2-41A3-950C-95AB2D0F8602</gtr:id><gtr:impact>Publication in Hypertension: 
Serum chloride is an independent predictor of mortality in hypertensive patients.
McCallum et al Hypertension 2013</gtr:impact><gtr:outcomeId>cWir27u5uxT</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Member of Glasgow BP clinic data analysis group</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>I have completed a study which used gadolinium enhanced cardiac MRI to identify non-ischaemic cardiac fibrosis in subjects with Primary Aldosteronism. This phenomenon was rarely seen in subjects with equivalent essential hypertension</gtr:description><gtr:id>F10F7194-68CA-4DC2-A699-2CD45177CCEF</gtr:id><gtr:impact>My clinical practice changed- target aldosterone excess as well as blood pressure in Primary Aldosteronism</gtr:impact><gtr:outcomeId>YJXTwjGdFSF</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Cardiac MRI in Primary Aldosteronism</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Development and validation of a tool to image and measure adrenal gland volume using Magnetic Resonance Imaging.</gtr:description><gtr:id>99790C8E-DF88-411C-A181-C70B41D2C3D0</gtr:id><gtr:impact>Has resulted in formal collaboration with University of Dundee; now acting as a further recruitment centre for my principal clinical study. In addition, has resulted in 2 methodology papers currently being prepared for submission.</gtr:impact><gtr:outcomeId>r83u6GcdTUv</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Imaging and measurement of adrenal volume using MRI</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>3269186B-4AD7-4851-BC37-CA01A3222B6A</gtr:id><gtr:title>Response to Effect of serum chloride on mortality in hypertensive patients.</gtr:title><gtr:parentPublicationTitle>Hypertension (Dallas, Tex. : 1979)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/030f715448cbe5ebed23ea9c8ac38a6b"><gtr:id>030f715448cbe5ebed23ea9c8ac38a6b</gtr:id><gtr:otherNames>McCallum L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0194-911X</gtr:issn><gtr:outcomeId>545b3facdc26b3.66221645</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A7E1AE0-C328-4669-AA68-315E0070EC37</gtr:id><gtr:title>Role of genetic variation in regulation of aldosterone biosynthesis.</gtr:title><gtr:parentPublicationTitle>Endocrine development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc470cd2f13415638d337587c37a73f5"><gtr:id>bc470cd2f13415638d337587c37a73f5</gtr:id><gtr:otherNames>Alvarez-Madrazo S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1421-7082</gtr:issn><gtr:outcomeId>cmNMgxbnvJA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>93FD469D-0A7A-41EE-87EB-5F4106A1603B</gtr:id><gtr:title>Urinary sodium excretion is the main determinant of mineralocorticoid excretion rates in patients with chronic kidney disease.</gtr:title><gtr:parentPublicationTitle>Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c7116c914d14539ce3b3f3c31334b2cb"><gtr:id>c7116c914d14539ce3b3f3c31334b2cb</gtr:id><gtr:otherNames>McQuarrie EP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0931-0509</gtr:issn><gtr:outcomeId>pm_14607_27_23413088</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FBF61E97-EC8E-460E-838B-B7BCFA182AF4</gtr:id><gtr:title>Management of metastatic phaeochromocytoma and paraganglioma: use of iodine-131-meta-iodobenzylguanidine therapy in a tertiary referral centre.</gtr:title><gtr:parentPublicationTitle>QJM : monthly journal of the Association of Physicians</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b77dc70911b0472b3dcf1a3d63e0e9c"><gtr:id>5b77dc70911b0472b3dcf1a3d63e0e9c</gtr:id><gtr:otherNames>Rutherford MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1460-2393</gtr:issn><gtr:outcomeId>doi_55f9459451562ef8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5296B907-04B7-4857-96E2-BA6F080446F3</gtr:id><gtr:title>Association between urinary sodium, creatinine, albumin, and long-term survival in chronic kidney disease.</gtr:title><gtr:parentPublicationTitle>Hypertension (Dallas, Tex. : 1979)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c7116c914d14539ce3b3f3c31334b2cb"><gtr:id>c7116c914d14539ce3b3f3c31334b2cb</gtr:id><gtr:otherNames>McQuarrie EP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0194-911X</gtr:issn><gtr:outcomeId>545b417057b6d8.38344052</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C52181C-AAF8-4CBF-A5A0-10661E14F1EF</gtr:id><gtr:title>Alterations in vascular function in primary aldosteronism: a cardiovascular magnetic resonance imaging study.</gtr:title><gtr:parentPublicationTitle>Journal of human hypertension</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/06ad3fdeea15079cec7bd787c4ccb2c1"><gtr:id>06ad3fdeea15079cec7bd787c4ccb2c1</gtr:id><gtr:otherNames>Mark PB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0950-9240</gtr:issn><gtr:outcomeId>pm_14607_27_23884211</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4B4CAEF4-91A5-405E-8F99-6B1F91597CA3</gtr:id><gtr:title>ACTH and Polymorphisms at Steroidogenic Loci as Determinants of Aldosterone Secretion and Blood Pressure.</gtr:title><gtr:parentPublicationTitle>International journal of molecular sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/25274b77d0eeb5a0161314580b10c515"><gtr:id>25274b77d0eeb5a0161314580b10c515</gtr:id><gtr:otherNames>MacKenzie SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1422-0067</gtr:issn><gtr:outcomeId>5a66133b4823e0.90731430</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1A892D97-76D8-4C9B-8997-CFB51AD9AC61</gtr:id><gtr:title>Demonstration of blood pressure-independent noninfarct myocardial fibrosis in primary aldosteronism: a cardiac magnetic resonance imaging study.</gtr:title><gtr:parentPublicationTitle>Circulation. Cardiovascular imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2f74e46ab82150d53c6b4aad1bb8920b"><gtr:id>2f74e46ab82150d53c6b4aad1bb8920b</gtr:id><gtr:otherNames>Freel EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1941-9651</gtr:issn><gtr:outcomeId>pm_14607_27_23019275</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>55A888B2-D7C2-45B7-A0A0-188B6E5D9B73</gtr:id><gtr:title>An unusual cause of mineralocorticoid hypertension.</gtr:title><gtr:parentPublicationTitle>Hypertension (Dallas, Tex. : 1979)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2f74e46ab82150d53c6b4aad1bb8920b"><gtr:id>2f74e46ab82150d53c6b4aad1bb8920b</gtr:id><gtr:otherNames>Freel EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0194-911X</gtr:issn><gtr:outcomeId>545b3facb65869.73261080</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>753110C5-D7F5-45B6-9CD3-8E8353E46ED5</gtr:id><gtr:title>A phaeochromocytoma occurring in a patient with Parkinson's disease on L-dopa therapy: a diagnostic challenge.</gtr:title><gtr:parentPublicationTitle>Clinical endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a8f6c013537fbd4b7111eb8f7d958ced"><gtr:id>a8f6c013537fbd4b7111eb8f7d958ced</gtr:id><gtr:otherNames>Collier A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0300-0664</gtr:issn><gtr:outcomeId>pm_14607_27_22044043</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A1200FB1-F81E-400A-B2F6-F18D89F7BDD9</gtr:id><gtr:title>Disorders of blood pressure regulation-role of catecholamine biosynthesis, release, and metabolism.</gtr:title><gtr:parentPublicationTitle>Current hypertension reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/03103cd5b601bdffa5481e8ddb74b538"><gtr:id>03103cd5b601bdffa5481e8ddb74b538</gtr:id><gtr:otherNames>Currie G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1522-6417</gtr:issn><gtr:outcomeId>GpEtaTkkjKt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>96F77E03-F045-49FE-A35D-D914CFB8C8F4</gtr:id><gtr:title>Aldosterone, vascular endothelial growth factor, and preeclampsia: a mystery solved?</gtr:title><gtr:parentPublicationTitle>Hypertension (Dallas, Tex. : 1979)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8adfe3efdb71b301f01f7011f70be061"><gtr:id>8adfe3efdb71b301f01f7011f70be061</gtr:id><gtr:otherNames>Delles C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0194-911X</gtr:issn><gtr:outcomeId>pm_14607_27_23460279</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B482E4EB-6ADB-4518-B208-5EED6CA8A57C</gtr:id><gtr:title>Adrenal venous sampling for catecholamines: a normal value study.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2f74e46ab82150d53c6b4aad1bb8920b"><gtr:id>2f74e46ab82150d53c6b4aad1bb8920b</gtr:id><gtr:otherNames>Freel EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>iahh9hAPii1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D580FB72-5BBD-4ED3-9D5E-510D70465603</gtr:id><gtr:title>Serum chloride is an independent predictor of mortality in hypertensive patients.</gtr:title><gtr:parentPublicationTitle>Hypertension (Dallas, Tex. : 1979)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/030f715448cbe5ebed23ea9c8ac38a6b"><gtr:id>030f715448cbe5ebed23ea9c8ac38a6b</gtr:id><gtr:otherNames>McCallum L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0194-911X</gtr:issn><gtr:outcomeId>545b4108385459.11730105</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>27392824-C8E1-40AB-8CEA-C8E455C957C8</gtr:id><gtr:title>Molecular analysis of pheochromocytoma after maternal transmission of SDHD mutation elucidates mechanism of parent-of-origin effect.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/18f3a509f3ad8a952e80c69566bb5a88"><gtr:id>18f3a509f3ad8a952e80c69566bb5a88</gtr:id><gtr:otherNames>Yeap PM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>i3ut9NE3UPx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>55FE7659-C979-4764-BC95-AC12C5C7D452</gtr:id><gtr:title>Assessment of the accuracy and reproducibility of adrenal volume measurements using MRI and its relationship with corticosteroid phenotype: a normal volunteer pilot study.</gtr:title><gtr:parentPublicationTitle>Clinical endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2f74e46ab82150d53c6b4aad1bb8920b"><gtr:id>2f74e46ab82150d53c6b4aad1bb8920b</gtr:id><gtr:otherNames>Freel EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0300-0664</gtr:issn><gtr:outcomeId>pm_14607_27_23469866</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>86CEAD76-6BCB-4C34-A20B-305D9C7FB3D3</gtr:id><gtr:title>Urinary corticosteroid excretion predicts left ventricular mass and proteinuria in chronic kidney disease.</gtr:title><gtr:parentPublicationTitle>Clinical science (London, England : 1979)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c7116c914d14539ce3b3f3c31334b2cb"><gtr:id>c7116c914d14539ce3b3f3c31334b2cb</gtr:id><gtr:otherNames>McQuarrie EP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0143-5221</gtr:issn><gtr:outcomeId>pm_14607_27_22397469</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB5352E4-553B-4038-AA0B-F62E87228423</gtr:id><gtr:title>Urinary free (unconjugated) metadrenalines in different hereditary forms of catecholamine-secreting phaeochromocytoma/paraganglioma.</gtr:title><gtr:parentPublicationTitle>Annals of clinical biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e123e0ef62242157c80ebfe90b81005b"><gtr:id>e123e0ef62242157c80ebfe90b81005b</gtr:id><gtr:otherNames>Davidson DF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0004-5632</gtr:issn><gtr:outcomeId>pm_14607_27_22914444</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0802803</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>160D22D0-5677-4513-A0AC-7F3526B7F336</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Metabolic and Endocrine</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>89AE580F-2437-4540-9640-37005C968E67</gtr:id><gtr:percentage>34</gtr:percentage><gtr:text>4.1  Discovery and preclinical testing of markers and technologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>